US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cerenome, Inc

3.08

-0.6050-16.44%

Volume:182.84K

Turnover:577.59K

Market Cap:21.10M

PE:-1.18

High:3.50

Open:3.43

Low:3.00

Close:3.68

52wk High:23.43

52wk Low:2.90

Shares:6.86M

Float Shares:6.34M

Volume Ratio:5.88

T/O Rate:2.88%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.6163

EPS(LYR):-7.2500

ROE:-614.05%

ROA:-135.36%

PB:3.86

PE(LYR):-0.42

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Calendar of U.S. Earnings Expected in the Week Ahead

Cerenome Q2 EPS $(1.31) Misses $(0.85) Estimate, Sales $411.000K Miss $1.110M Estimate

Benzinga Earnings

Plus Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Press Release: Cerenome Reports Second Quarter 2026 Financial Results and Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CNSY"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNSY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNSY\",,,,,undefined,":{"symbol":"CNSY","market":"US","secType":"STK","nameCN":"Cerenome, Inc","latestPrice":3.075,"timestamp":1786983843671,"preClose":3.68,"halted":0,"volume":182843,"delay":0,"changeRate":-0.16440217391304346,"floatShares":6339500,"shares":6862000,"eps":-2.616304,"marketStatus":"Trading","change":-0.605,"latestTime":"08-17 12:24:07 EDT","open":3.43,"high":3.5,"low":3,"amount":577587.5431866,"amplitude":0.13587,"askPrice":3.08,"askSize":1007,"bidPrice":3.07,"bidSize":1,"shortable":0,"etf":0,"ttmEps":-2.616304,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1786996800000},"marketStatusCode":2,"adr":0,"listingDate":1134968400000,"exchange":"NASDAQ","adjPreClose":3.68,"preHourTrading":{"tag":"盘前","latestPrice":3.49,"preClose":3.68,"latestTime":"09:29 EDT","volume":4492,"amount":14935.4481048,"timestamp":1786973345436,"change":-0.19,"changeRate":-0.05163,"amplitude":0.046196},"postHourTrading":{"tag":"盘后","latestPrice":3.27,"preClose":3.68,"latestTime":"19:50 EDT","volume":20364,"amount":68714.4463,"timestamp":1786751434052,"change":-0.41,"changeRate":-0.111413,"amplitude":0.127717},"volumeRatio":5.875718},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNSY\",,,,,undefined,":{"symbol":"CNSY","floatShares":6339500,"roa":"-135.36%","roe":"-614.05%","lyrEps":-7.25,"volumeRatio":5.875718,"shares":6862000,"dividePrice":0,"high":3.5,"amplitude":0.13587,"preClose":3.68,"low":3,"week52Low":2.9,"pbRate":"3.86","psRate":"5.02","week52High":23.425,"institutionHeld":0,"latestPrice":3.075,"committee":-0.998016,"eps":-2.616304,"divideRate":0,"volume":182843,"delay":0,"ttmEps":-2.616304,"open":3.43,"prevYearClose":12.8075,"prevWeekClose":3.68,"prevMonthClose":3.87,"prevQuarterClose":4.37,"fiveDayClose":3.84,"twentyDayClose":3.83,"sixtyDayClose":6.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNSY\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNSY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNSY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1775016000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNSY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNSY","date":"2026-08-14","current":-1.175322,"percent":0.777778,"low":-2.284561,"twenty":-2.237254,"median":-2.212448,"eighty":-2.134565,"high":-2.030721,"avg":-2.193409,"sd":0.070175,"marketCap":25467492},"quantilePoints":[{"date":"2026-08-07","current":-2.22687,"twenty":-2.261485,"median":-2.232639,"eighty":-2.18764,"marketCap":26568789},{"date":"2026-08-14","current":-2.134565,"twenty":-2.237254,"median":-2.212448,"eighty":-2.134565,"marketCap":25467492}],"updateTime":1786983847415},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNSY\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660891784","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2660891784","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660891784?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:00","pubTimestamp":1786960800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ·Amer Sports Inc.                                  2Q       .11    6:00 AM. ·Home Depot Inc.                                   2Q      4.73    6:00 AM. ·Pony AI ADR                                     2Q      (.15)   5:00 AM. ·BILL Hldgs Inc                                  4Q       .71    4:01 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLO","CNSY","FBRX","LOW","ADI","AS","KEYS","KC","MRKR","LZB","BEKE","JKHY","HD","KLAR","ATHM","ADIL","ZTO","CAAP","LYTS","ANF","DCGO","ANVS","HSAI","BEEM","LONA","FUTU","DE","HTHT","DOMO","HAIN","IQ","FN","AAP","COTY","GGAL","BABA","FLNG","ALVO","FLUX","BILL","IMTX","NDSN","ATAT","BIDU","MBRX","XP","BJ","EL","MRCY","BMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659041121","title":"Cerenome Q2 EPS $(1.31) Misses $(0.85) Estimate, Sales $411.000K Miss $1.110M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659041121","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659041121?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:12","pubTimestamp":1786741958,"startTime":"0","endTime":"0","summary":"Cerenome (NASDAQ:CNSY) reported quarterly losses of $(1.31) per share which missed the analyst consensus estimate of $(0.85) by 54.12 percent. This is a 718.75 percent decrease over losses of $(0.16) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61231587/cerenome-q2-eps-1-31-misses-0-85-estimate-sales-411-000k-miss-1-110m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cerenome Q2 EPS $(1.31) Misses $(0.85) Estimate, Sales $411.000K Miss $1.110M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNSY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659412153","title":"Plus Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659412153","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659412153?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:46","pubTimestamp":1786740367,"startTime":"0","endTime":"0","summary":"Plus Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryPlus Therapeutics IncCNSY.OQreported a quarterly adjusted loss of $1.31 per share for the quarter ended June 30, l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B1KR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNSY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659412930","title":"Press Release: Cerenome Reports Second Quarter 2026 Financial Results and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659412930","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659412930?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:15","pubTimestamp":1786738500,"startTime":"0","endTime":"0","summary":"August 3, 2026, with the Company's common stock trading on the Nasdaq. Capital Market under the ticker symbol \"CNSY\"REYOBIQ Development-- Continued enrollment in the ReSPECT-LM multiple-dose clinical trial. As. of June 30, 2026, approximately one-third of patients had been enrolled,with no dose-limiting toxicities observed to date, supporting the. development of a recommended Phase 2 dose/dosing regimen by year-end. -- Continued enrollment in the ReSPECT-GBM Phase 2 trial. Current enrollment. rates indicate full enrollment in 2026 followed by a data readout and a. subsequent End-of-Phase 2 meeting with the U.S. Food and Drug. -- Initial site activation of the ReSPECT-PBC pediatric brain cancer Phase 1. trial at Lurie Children's Hospital. First dosing expected in the third. -- Continued commercial-level manufacturing scale-up and supply chain. enhancement for REYOBIQ drug supplyCNSide CSF Assay Platform-- Performed 232 CNSide cerebrospinal fluid tests during the first half of. 2026 and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4202","BK4099","BK4588","TM","CNSY","BK4585","BK4555","R","LCLG","BK4022","BK4139","NCI","BK4604","BK4232"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CNSY\",params:#limit:6,delay:false,,,undefined,":[]}}